
|Videos|August 18, 2022
Historic and Current Treatment Options for mUM
Author(s)Sunandana Chandra, MD, MS
An expert provides an overview of the historical and currently available treatment options in metastatic uveal melanoma (mUM), including the bispecific T-cell receptor immunotherapy tebentafusp (“teh-BEN-tah-fuhsp”).
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
Top 5 Takeaways From ASCO 2026 That Patients Should Know
2
Pumitamig Shows 70% Response in Advanced Lung Cancer Regardless of PD-L1 Status
3
Nurse-Led Quality Initiative Reduces CLABSI Risk in Hematologic Cancer Care
4
Medical Cannabis Education Improves Oncology Nurses’ Confidence in Patient Discussions
5

